Supernus Pharmaceuticals SUPN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$2.29M+44.1% | -$4.11M+90.9% | -$45.12M-301% | $22.5M+290% | -$11.83M-177% | ||
| $26.13M+4.5% | $25.02M+0.8% | $24.81M+16.1% | $21.36M+4.8% | $20.38M+8.2% | ||
| $8.48M-12.1% | $9.65M+23.3% | $7.83M+4.2% | $7.51M-7.0% | $8.07M+5.7% | ||
| $66.52M+235% | $19.86M— | —— | $58.54M+91.3% | $30.6M-31.1% | ||
| $0-100% | $427K+231% | $129K-71.6% | $455K+39.1% | $327K+53.5% | ||
| -$19.22M— | —— | $48.71M— | —— | $37.32M+395% | ||
| $9.12M+6.9% | $8.53M-59.5% | $21.07M+2,153% | $935K+104% | -$21.4M-463% | ||
| $56.42M— | —— | $8.11M-71.9% | $28.86M-38.0% | $46.52M— | ||
| $66.52M+242% | $19.43M— | —— | $58.08M+91.9% | $30.27M-31.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Supernus Pharmaceuticals generate?
- Supernus Pharmaceuticals (SUPN) generated $175.5M in operating cash flow over the trailing twelve months.
- What is Supernus Pharmaceuticals's free cash flow?
- After $1.0M of capital expenditures, Supernus Pharmaceuticals's free cash flow was $174.3M over the trailing twelve months, up 1.8% year over year.
- Where does Supernus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
